Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Fennimore

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Gastroenterology|October 4, 2015
A rare cause of postprandial abdominal pain and nauseaMichael Kriss, Jeffrey Kaplan, Blair Fennimore
Inflammatory Bowel Diseases|August 19, 2016
Inflammatory Bowel Disease: Influence and Implications in ReproductionLouise E Glover, Blair Fennimore, Mary Wingfield
Journal of Molecular Medicine (Berlin, Germany)|January 9, 2013
Adenosine and gastrointestinal inflammationSean P Colgan, Blair Fennimore, Stefan F Ehrentraut
The American Journal of Gastroenterology|December 5, 2012
Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costsGregory L Austin, Blair Fennimore, Dennis J Ahnen
Gastro Hep Advances|August 12, 2024
Temporal Trends in Perceptions of Anti-tumor Necrosis Factor Risks and Benefits in an Online Community of Patients With Crohn's DiseaseAmneet K Hans, Mark E Gerich, Blair Fennimore, et al.
Molecular Biology of the Cell|December 25, 2009
Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epitheliaSimon Keely, Louise E Glover, Thomas Weissmueller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's DiseaseFrank I Scott, Amneet K Hans, Mark E Gerich, et al.
Journal of Crohn'S & Colitis|January 5, 2020
Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative ColitisFrank I Scott, Michelle Luo, Yash Shah, et al.
Pediatrics|February 22, 2022
Delays Related to Prior Authorization in Inflammatory Bowel DiseaseBrad D Constant, Edwin F de Zoeten, Marisa G Stahl, et al.
Clinical Pharmacokinetics|February 5, 2021
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel DiseaseWan Sun, Blair Fennimore, Dawn B Beaulieu, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Gastroenterology|October 4, 2015
A rare cause of postprandial abdominal pain and nauseaMichael Kriss, Jeffrey Kaplan, Blair Fennimore
Inflammatory Bowel Diseases|August 19, 2016
Inflammatory Bowel Disease: Influence and Implications in ReproductionLouise E Glover, Blair Fennimore, Mary Wingfield
Journal of Molecular Medicine (Berlin, Germany)|January 9, 2013
Adenosine and gastrointestinal inflammationSean P Colgan, Blair Fennimore, Stefan F Ehrentraut
The American Journal of Gastroenterology|December 5, 2012
Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costsGregory L Austin, Blair Fennimore, Dennis J Ahnen
Gastro Hep Advances|August 12, 2024
Temporal Trends in Perceptions of Anti-tumor Necrosis Factor Risks and Benefits in an Online Community of Patients With Crohn's DiseaseAmneet K Hans, Mark E Gerich, Blair Fennimore, et al.
Molecular Biology of the Cell|December 25, 2009
Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epitheliaSimon Keely, Louise E Glover, Thomas Weissmueller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's DiseaseFrank I Scott, Amneet K Hans, Mark E Gerich, et al.
Journal of Crohn'S & Colitis|January 5, 2020
Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative ColitisFrank I Scott, Michelle Luo, Yash Shah, et al.
Pediatrics|February 22, 2022
Delays Related to Prior Authorization in Inflammatory Bowel DiseaseBrad D Constant, Edwin F de Zoeten, Marisa G Stahl, et al.
Clinical Pharmacokinetics|February 5, 2021
Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel DiseaseWan Sun, Blair Fennimore, Dawn B Beaulieu, et al.
Pageof 2